News Releases

Orgenesis Included in Juvenile Diabetes Cure Alliance 2015 Update of Emerging Practical Cure Projects
Aug 31, 2015

Orgenesis Subsidiary MaSTherCell to Manufacture TxCell’s Lead Product Ovasave for Multi-National Phase 2b Trial
Jul 29, 2015

Orgenesis to Present at 3rd Global Life Sciences Conference in Warsaw
Jun 08, 2015

Orgenesis Founder Dr. Sarah Ferber to Present at American Diabetes Association's 75th Scientific Sessions
Jun 05, 2015

Orgenesis Wins Deal of the Month by Acquisition International Magazine
May 22, 2015

MaSTherCell And Curecell Sign Memorandum Of Understanding For Cell Therapy Partnership
May 22, 2015

Orgenesis to Present at the 16th Annual B. Riley Investor Conference
May 07, 2015

Investment Fund Manager, Chris Buyse, Appointed to Orgenesis Board
Apr 16, 2015

CEO of MaSTherCell, Hugues Bultot, Joins Orgenesis Board of Directors
Apr 15, 2015

Orgenesis Signs Cell Therapy Product Development Memorandum of Understanding with CureCell of Korea
Apr 08, 2015



RSS Feed

icon-rss Preview or subscribe to our news feed here.


Historical Press Releases

This website contains historical and archived press releases for Orgenesis Inc. The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, Orgenesis Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

Back to Top